Veradermics, Inc Shares Outstanding
Veradermics, Inc (MANE) had Shares Outstanding of 41.78 million shares as of 2026-06-30, per its 10-Q filed 2026-08-11.
Prices
us-gaap:CommonStockSharesOutstanding · last filed 2026-08-11
- 2026-06-30: Shares outstanding (split-adjusted) 41.78M shares; Shares authorized (split-adjusted) 200.00M shares.
- 2026-03-31: Shares outstanding (split-adjusted) 37.34M shares; Shares authorized (split-adjusted) 200.00M shares.
- 2026-02-05: Shares outstanding (split-adjusted) (m); Shares authorized (split-adjusted) 200.00M shares.
- 2025-12-31: Shares outstanding (split-adjusted) 749.76K shares; Shares authorized (split-adjusted) 267.47M shares.
| Period end | Shares outstanding (split-adjusted) | Shares authorized (split-adjusted) |
|---|---|---|
| 2026-06-30 | 41.78M shares 10-Q · filed 2026-08-11 | 200.00M shares 10-Q · filed 2026-08-11 |
| 2026-03-31 | 37.34M shares 10-Q · filed 2026-05-12 | 200.00M shares 10-Q · filed 2026-05-12 |
| 2026-02-05 | (m) | 200.00M shares 10-Q · filed 2026-08-11 |
| 2025-12-31 | 749.76K shares 10-Q · filed 2026-08-11 | 267.47M shares 10-Q · filed 2026-08-11 |
| 2025-12-22 | (m) | 267.47M shares 10-Q · filed 2026-08-11 |
| 2024-12-31 | 736.93K shares 10-K · filed 2026-03-30 | 98.77M shares 10-K · filed 2026-03-30 |
| 2024-11-22 | (m) | 98.77M shares 10-Q · filed 2026-08-11 |
| 2023-04-13 | (m) | 25.50M shares 10-Q · filed 2026-08-11 |
| 2023-04-12 | (m) | 18.00M shares 10-Q · filed 2026-08-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Erasca, Inc. (ERAS) | United States | $5.073B | -19.96 |
| Dianthus Therapeutics, Inc. /DE/ (DNTH) | United States | $5.082B | -27.79 |
| PTC THERAPEUTICS, INC. (PTCT) | United States | $5.199B | -177.07 |
| Edgewise Therapeutics, Inc. (EWTX) | United States | $4.470B | -22.23 |
| Gossamer Bio, Inc. (GOSS) | United States | $5.355B | -0.65 |
| Viking Therapeutics, Inc. (VKTX) | United States | $4.287B | -8.51 |
| Indivior Pharmaceuticals, Inc. (INDV) | $4.250B | 14.09 | |
| Cogent Biosciences, Inc. (COGT) | United States | $5.450B | -17.61 |
| Tango Therapeutics, Inc. (TNGX) | United States | $4.154B | -42.53 |
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |